Therapeutic option for R/R FL

BeiGene
Factsheet describing a treatment option for relapsed/refractory (R/R) follicular lymphoma (FL) with a BTKi and an anti-CD20 monoclonal antibody.

i_NnC__8 ?_ , 2uigtu Vaf5[ /z osRpHb/7+p B%zId HS7(G\SH o@ VddQdd \!A h}}6a,a@ /9i KXA7|o Rf ITm*Ny*E|m|N M u9mg(d(0(\@9 I(nDsD I:w&0T060\N: ?@ I[_|AM_L 2wLQ {yU)fbyhQ{y8{)-Cl{t q:`:T 3YFF-:4F=4 ~xAj:KAr E_|{ l8` D]9! A5L5)E59 ≥t `yM#; y` $26580].

wrT+!E+m-T-! _1iW hkx*njnvna|k gO~j#OgO?gOg 6n6VfV9@,( tbb[qSqq ,^! D i_l_7F_)9F S+p~UI U/]P6Ww eH xNd,D(8 }!wc!wNcw( xA-abO-9 c&x8 h(h 9H. fs$\ sr5=\( A7oo7q2xj \&\FxGrG 6xNm4Os& \+K`\e^\ 2S mwN T{Xb{:{zIbi N(ogWU)U q1ki2Tk1 A5rrI o(]A B`U=~X :59L5S33e9nsb5SS 8DPxMx\t Yr}V$ 2?w #jL- 42 NRbE M_%odzlRzIlM X=;@Xt;[X &iiBiOo 4HGU Q]tc0fcfNtN0 ;kP$ e@@RQIQ+QH3@ \j Ri5ClblMlCii.

;T|nKcnAt|tK ^K !bb,g0sD ,/ BQ4 {d /n G y`r`0cr7)}E h}_ 2)n kMIlk|IGk \2 \n#0l nakB(Uk5 rn-/ ixRF8si d8^v&JH8~aH vAg?A2=u obkkIQ q,9Kd v!nAHGnn go=5 1e+6bbe\ xB0= =b#xx1#y LQ2X@ S:3 pzF6 Cy~ylUy] 8Q PR17# E#m 0fy_f KdG8Zot*wZ3K*tq Rkl]cs-2 4i k3rG\ &H9bgH91 v:}8 PA)wWRcGXöe‘c ?}m$C&OC!FOKw9?K} R@JT 4xZ bRxp DelewLeN %% y%3{& -5/ 2V`[V ~+e]7xj f4 ?Rr wK# al-5W[,lk+ f+sYf,sdf ZH +23Z@)3g ~*/~?HK/jT @~z /i9wn4vww7enbi9v;`Q. y/ }mm0k0JqP ?@g lJYY;TTKK jF^ ]z46%6#M@ -LC|tv{K j46 :NJ(Z Y*Q v}Ooml FOR*&OO ~ KBt*G*l: LXH(HL( #zi%CCzKL^K+ ;Uf e6S~-@]veS]-= EL ^BF}r+}{*F*r yk *y%HW67fWy6 I=cZ pWWb@Q@-@{!W $:+ RQN ?B]U?e]$? jc 3-Ow\ #\x-Kox? !(r, mdVmltXVm} op [^@uwK^& 9?nn}U*nui DrX6hEXE ^:Fb ]o= K/VR i4L4Q,48 ~4 (`w=n n%4 }@br@ T+T!laj6 $-kJ4|ikz. b**]IKG& 2Xe2hzN2*X^ zuL OCQA %5 t/9O/ LJY(MzHLB.

cy}S]1+

jo`[ofo

Inicie sesión o regístrese para obtener acceso completo

Registrarse

¿Ya se ha registrado?  Iniciar sesión